Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, originally developed to treat type 2 diabetes, has become one of the most effective medications for sustainable weight loss, with clinical trials showing average reductions of 15-22% of body weight over 68 weeks. However, not everyone is a candidate, and understanding your personal eligibility requires looking at your metabolic health, medical history, and lifestyle factors. PlexusDx specializes in personalized semaglutide therapy, matching patients with the right formulation and dose based on individual physiology.

What Semaglutide Does and Why People Choose It for Weight Loss

Semaglutide is a GLP-1 receptor agonist—a medication that mimics glucagon-like peptide-1, a hormone your body naturally produces to regulate appetite and blood sugar. When you take semaglutide, it signals your brain's satiety centers, reduces hunger hormone production, and slows stomach emptying, all of which work together to decrease calorie intake without requiring extreme willpower or restriction. Patients typically experience reduced cravings, earlier fullness during meals, and less obsessive thinking about food.

The medication also improves metabolic markers beyond weight alone. Users often see improvements in blood pressure, cholesterol levels, inflammation markers, and fasting glucose, even independent of weight loss itself. This metabolic reset is particularly valuable for people whose weight has been resistant to diet and exercise alone, or those with family histories of metabolic dysfunction.

Ideal Candidates for Semaglutide Weight Loss Therapy

The most suitable candidates for semaglutide typically have a BMI of 30 or higher (obesity), or a BMI of 27-29.9 (overweight) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or elevated cholesterol. If you have struggled with weight loss despite consistent diet and exercise efforts over months or years, semaglutide addresses a genuine physiological barrier rather than a behavioral one. Adults aged 18 and older with stable medical conditions and no contraindications are generally appropriate candidates.

Beyond numbers, ideal candidates are those motivated to make lasting lifestyle changes alongside medication. Semaglutide works best when combined with consistent physical activity, adequate protein intake, and mindful eating habits. Patients who view semaglutide as a metabolic tool—not a magic solution—tend to achieve the best long-term outcomes and maintain weight loss after discontinuing the medication.

Medical Conditions That May Affect Your Eligibility

Certain medical histories require careful evaluation before starting semaglutide. A personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia type 2 (MEN2) is a contraindication, meaning semaglutide should not be used. Additionally, those with a history of pancreatitis, severe gallbladder disease, or uncontrolled psychiatric conditions may need alternative approaches. Pregnancy and breastfeeding are also contraindications, as semaglutide's effects on fetal development have not been fully established.

If you take insulin or other diabetes medications, semaglutide can be combined with these therapies, but dosing adjustments and closer monitoring are necessary to prevent low blood sugar episodes. Patients with kidney disease, liver disease, or a history of diabetic retinopathy should discuss semaglutide with their provider to weigh benefits against risks. PlexusDx requires a complete health questionnaire before enrollment to identify any potential safety concerns and ensure personalized, appropriate treatment.

How PlexusDx Personalizes Your Semaglutide Experience

PlexusDx offers compounded semaglutide injections starting at $149 per month, delivered to all 50 states without requiring insurance or membership fees. Unlike one-size-fits-all dosing protocols, PlexusDx tailors semaglutide strength and administration to your individual tolerance, metabolic rate, and weight loss goals. Your dose may need to go up, but your price won't—PlexusDx maintains flat monthly pricing across all dose levels, so you're never penalized for needing stronger concentrations as your body adapts.

For patients interested in understanding their genetic predispositions toward GLP-1 responsiveness, PlexusDx offers the Precision Peptide Genetic Test for an additional $99 after the first month of treatment. This test analyzes 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and GIPR rs1800437, which influence how effectively your body responds to semaglutide and other weight loss compounds. This genetic insight allows your treatment plan to evolve based on your unique biology rather than guesswork.

Getting Started: Steps to Determine If Semaglutide Is Right for You

The first step is completing PlexusDx's detailed health questionnaire, which captures your weight history, current medications, past medical conditions, family history, and lifestyle factors. This information helps PlexusDx clinicians assess whether semaglutide aligns with your health profile and whether any dose adjustments or monitoring protocols are necessary. If you have recent lab work (blood glucose, lipid panel, liver and kidney function), have it on hand, though PlexusDx will guide you on what is needed.

Once cleared, you'll begin with a starting dose calibrated to your tolerance threshold—most patients begin at a conservative dose and gradually increase over weeks to reach their therapeutic level. PlexusDx provides detailed injection instruction videos and ongoing support via the patient portal to ensure you feel confident and safe administering your medication at home. Regular check-ins help track your progress, adjust dosing if needed, and catch any side effects early so they can be managed effectively.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need to be diabetic to take semaglutide for weight loss?

No. While semaglutide was originally approved for type 2 diabetes, it is now widely prescribed for weight loss in non-diabetic adults with a BMI of 30 or higher, or a BMI of 27-29.9 with weight-related health conditions. PlexusDx serves both diabetic and non-diabetic patients, adjusting protocols based on your metabolic needs.

What clinical evidence supports semaglutide for weight loss?

The STEP trials demonstrated that semaglutide led to average weight loss of 15-22% over 68 weeks compared to 2-3% with placebo. Participants also showed improvements in blood pressure, cholesterol, and inflammation markers. These large-scale trials established semaglutide as one of the most effective pharmacological interventions for sustainable weight loss.

Is PlexusDx's compounded semaglutide FDA-approved?

PlexusDx semaglutide is compounded by licensed 503A pharmacies under strict quality standards, but compounded medications are not FDA-approved in the traditional sense. However, they are legally permitted and regulated by state pharmacy boards. Many patients choose compounded options for cost savings and personalization while maintaining high safety standards.

What are the most common side effects of semaglutide?

The most frequent side effects are gastrointestinal: nausea, vomiting, constipation, and diarrhea, typically mild and temporary as your body adjusts. Rare but serious side effects include pancreatitis, gallbladder issues, and kidney problems. PlexusDx monitors patients closely and provides strategies to minimize GI discomfort, such as eating smaller meals and staying hydrated.

Can the Precision Peptide Genetic Test predict how well semaglutide will work for me?

The Precision Peptide Genetic Test analyzes genetic variants like GLP1R rs6923761 and FTO rs9939609 that influence your metabolism and GLP-1 pathway sensitivity. While genetics are not destiny, knowing your predispositions helps PlexusDx optimize your dosing strategy and identify whether alternative compounds like tirzepatide might be more effective for your biology.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves